UCSF

ZINC01552174

Substance Information

In ZINC since Heavy atoms Benign functionality
October 6th, 2004 27 Yes

Other Names:

2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-

2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-; 2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetr

2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-

2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-

3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone

3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril

6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone

6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril

6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one

6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one

73963-72-1

73963-72-1; Cilostazol (JP16/USAN/INN); D01896; Pletal (TN)

89332-50-3

AC-4334

AC1L1EE2

BRD-K67017579-001-04-2

BRD-K67017579-001-05-9

BRD-K67017579-001-07-5

BRD-K67017579-001-13-3

BRD-K67017579-001-17-4

BRN 3632107

BSPBio_002759

C 0737

C045645

C0737_SIGMA

C20H27N5O2

CHEBI:150440

CHEBI:31401

CHEMBL799

CID2754

Cilostazol (BAN

Cilostazol (JP15/USAN/INN)

Cilostazol [INN:JAN]

cilostazol; cilostazolum

CILOSTAZOL; CPD000058428; SAM001246734

CILOSTAZOL; CPD000058428; SAM001247085

Cilostazole

Cilostazole;Cilostazolum [INN-Latin]

Cilostazolum

Cilostazolum [INN-Latin]

Cilostazolum [INN-Latin];Cilostazole

CL23867

CPD000058428

CPD000058428; Cilostazol; SAM001246734

CPD000058428; Cilostazol; SAM001247085

D01896

DAP000191

DB01166

EU-0100218

FDA

HMS1922N15

HMS2093M14

INN

JAN

KBio3_002259

KBioGR_001184

LS-142693

MFCD00866780

MFCD08063421

MLS000028470

MLS000758281

MLS000759507

MLS001076067

MLS002153891

MolPort-001-758-007

NCGC00015207-01

NCGC00015207-02

NCGC00015207-06

NCGC00015207-10

NCGC00022153-02

NCGC00022153-04

NCGC00022153-05

NCGC00022153-06

NCGC00022153-07

OPC 13013

OPC 21

OPC-13013

OPC-13013; OPC-21

OPC-21

Otsuka brand of cilostazol

Pletaal

Pletal

Pletal (TN)

Pletal, Cilostazol

QA-7420

S1294_Selleck

SAM001246734

SAM001247085

SMR000058428

SPBio_001256

SPECTRUM1505230

Spectrum2_001118

Spectrum3_001170

Spectrum4_000772

Spectrum5_001762

TL8005113

Tocris-1692

UNII-N7Z035406B

USAN)

ZINC01552174

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.40 8.68 -16.36 1 7 0 82 369.469 7

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 3.24e-02 g/l DrugBank-approved
Purity 99% APIChem
Indications intermittent claudication KeyOrganics Bioactives
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP03506c NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 1692 NIH Clinical Collection via PubChem
Target PDE Selleck Chemicals
Therapy phosphodiesterase inhibitor SMDC Iconix
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP03506c NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 1692 NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 10000 0.26 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
Z50425 Z50425 Plasmodium Falciparum 10000 0.26 Functional ≤ 10μM

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.